Retinol-binding protein 4 and its membrane receptor STRA6 control adipogenesis by regulating cellular retinoid homeostasis and retinoic acid receptor α activity

Molecular and Cellular Biology

Volumn 33, Issue 20, 2013, Pages 4068-4082

  Muenzner, Matthias ^a   Tuvia, Neta ^a   Deutschmann, Claudia ^a   Witte, Nicole ^a   Tolkachov, Alexander ^a   Valai, Atijeh ^a   Henze, Andrea ^b   Sander, Leif E ^a   Raila, Jens ^b   Schupp, Michael ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF POTSDAM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN STRA6; RETINOIC ACID RECEPTOR ALPHA; RETINOID; RETINOL BINDING PROTEIN 4; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; HOMEOSTASIS; LIVER CELL; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; WHITE ADIPOSE TISSUE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HOMEOSTASIS; LIVER; MALE; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; OBESITY; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOL-BINDING PROTEINS, PLASMA; SIGNAL TRANSDUCTION; VITAMIN A;

EID: 84886932409     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00221-13     Document Type: Article

References (79)

1. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Naslund E, Britton T, Concha H, Hassan M, Ryden M, Frisen J, Arner P. 2008. Dynamics of fat cell turnover in humans. Nature 453:783-787.
2. Chambon P. 1996. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:940-954.
3. Zizola CF, Frey SK, Jitngarmkusol S, Kadereit B, Yan N, Vogel S. 2010. Cellular retinol-binding protein type I (CRBP-I) regulates adipogenesis. Mol. Cell. Biol. 30:3412-3420.
4. Zizola CF, Schwartz GJ, Vogel S. 2008. Cellular retinol-binding protein type III is a PPARgamma target gene and plays a role in lipid metabolism. Am. J. Physiol. Endocrinol. Metab. 295:E1358-E1368.
5. Ziouzenkova O, Orasanu G, Sharlach M, Akiyama TE, Berger JP, Viereck J, Hamilton JA, Tang G, Dolnikowski GG, Vogel S, Duester G, Plutzky J. 2007. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat. Med. 13:695-702.
6. Zhang M, Hu P, Krois CR, Kane MA, Napoli JL. 2007. Altered vitamin A homeostasis and increased size and adiposity in the rdh1-null mouse. FASEB J. 21:2886-2896.
7. Jeyakumar SM, Vajreswari A, Giridharan NV. 2006. Chronic dietary vitamin A supplementation regulates obesity in an obese mutant WNIN/Ob rat model. Obesity 14:52-59.
8. Mercader J, Ribot J, Murano I, Felipe F, Cinti S, Bonet ML, Palou A. 2006. Remodeling of white adipose tissue after retinoic acid administration in mice. Endocrinology 147:5325-5332.
9. Berry DC, DeSantis D, Soltanian H, Croniger CM, Noy N. 2012. Retinoic acid upregulates preadipocyte genes to block adipogenesis and suppress diet-induced obesity. Diabetes 61:1112-1121.
10. Ribot J, Felipe F, Bonet ML, Palou A. 2001. Changes of adiposity in response to vitamin A status correlate with changes of PPAR gamma 2 expression. Obes. Res. 9:500-509.
11. Bonet ML, Ribot J, Palou A. 2012. Lipid metabolism in mammalian tissues and its control by retinoic acid. Biochim. Biophys. Acta 1821:177-189.
12. Yasmeen R, Jeyakumar SM, Reichert B, Yang F, Ziouzenkova O. 2012. The contribution of vitamin A to autocrine regulation of fat depots. Biochim. Biophys. Acta 1821:190-197.
13. Safonova I, Darimont C, Amri EZ, Grimaldi P, Ailhaud G, Reichert U, Shroot B. 1994. Retinoids are positive effectors of adipose cell differentiation. Mol. Cell. Endocrinol. 104:201-211.
14. Reichert B, Yasmeen R, Jeyakumar SM, Yang F, Thomou T, Alder H, Duester G, Maiseyeu A, Mihai G, Harrison EH, Rajagopalan S, Kirkland JL, Ziouzenkova O. 2011. Concerted action of aldehyde dehydrogenases influences depot-specific fat formation. Mol. Endocrinol. 25:799-809.
15. Murray T, Russell TR. 1980. Inhibition of adipose conversion in 3T3-L2 cells by retinoic acid. J. Supramol. Struct. 14:255-266.
16. Kuri-Harcuch W. 1982. Differentiation of 3T3-F442A cells into adipocytes is inhibited by retinoic acid. Differentiation 23:164-169.
17. Kamei Y, Kawada T, Mizukami J, Sugimoto E. 1994. The prevention of adipose differentiation of 3T3-L1 cells caused by retinoic acid is elicited through retinoic acid receptor alpha. Life Sci. 55:PL307-PL312.
18. Xue JC, Schwarz EJ, Chawla A, Lazar MA. 1996. Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARgamma. Mol. Cell. Biol. 16:1567-1575.
19. Schwarz EJ, Reginato MJ, Shao D, Krakow SL, Lazar MA. 1997. Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription. Mol. Cell. Biol. 17:1552-1561.
20. Marchildon F, St-Louis C, Akter R, Roodman V, Wiper-Bergeron NL. 2010. Transcription factor Smad3 is required for the inhibition of adipogenesis by retinoic acid. J. Biol. Chem. 285:13274-13284.
21. Choy L, Derynck R. 2003. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancerbinding protein (C/EBP) and repressing C/EBP transactivation function. J. Biol. Chem. 278:9609-9619.
22. Sul HS, Smas CM, Wang D, Chen L. 1998. Regulation of fat synthesis and adipose differentiation. Prog. Nucleic Acid Res. Mol. Biol. 60:317-345.
23. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C. 1992. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 68:397-406.
24. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, Speck J, Kratzeisen C, Rosenberger M, Lovey A, et al. 1992. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature 355:359-361.
25. Canan Koch SS, Dardashti LJ, Cesario RM, Croston GE, Boehm MF, Heyman RA, Nadzan AM. 1999. Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells. J. Med. Chem. 42:742-750.
26. Yamauchi T, Waki H, Kamon J, Murakami K, Motojima K, Komeda K, Miki H, Kubota N, Terauchi Y, Tsuchida A, Tsuboyama-Kasaoka N, Yamauchi N, Ide T, Hori W, Kato S, Fukayama M, Akanuma Y, Ezaki O, Itai A, Nagai R, Kimura S, Tobe K, Kagechika H, Shudo K, Kadowaki T. 2001. Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes. J. Clin. Invest. 108:1001-1013.
27. Fu M, Sun T, Bookout AL, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. 2005. A nuclear receptor atlas: 3T3-L1 adipogenesis. Mol. Endocrinol. 19:2437-2450.
28. Repa JJ, Hanson KK, Clagett-Dame M. 1993. All-trans-retinol is a ligand for the retinoic acid receptors. Proc. Natl. Acad. Sci. U. S. A. 90:7293-7297.
29. Quadro L, Blaner WS, Salchow DJ, Vogel S, Piantedosi R, Gouras P, Freeman S, Cosma MP, Colantuoni V, Gottesman ME. 1999. Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J. 18:4633-4644.
30. Naylor HM, Newcomer ME. 1999. The structure of human retinolbinding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Biochemistry 38:2647-2653.
31. Berry DC, Croniger CM, Ghyselinck NB, Noy N. 2012. Transthyretin blocks retinol uptake and cell signaling by the holo-retinol-binding protein receptor STRA6. Mol. Cell. Biol. 32:3851-3859.
32. Kawaguchi R, Yu J, Honda J, Hu J, Whitelegge J, Ping P, Wiita P, Bok D, Sun H. 2007. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 315:820-825.
33. Kawaguchi R, Yu J, Ter-Stepanian M, Zhong M, Cheng G, Yuan Q, Jin M, Travis GH, Ong D, Sun H. 2011. Receptor-mediated cellular uptake mechanism that couples to intracellular storage. ACS Chem. Biol. 6:1041-1051.
34. Ruiz A, Mark M, Jacobs H, Klopfenstein M, Hu J, Lloyd M, Habib S, Tosha C, Radu RA, Ghyselinck NB, Nusinowitz S, Bok D. 2012. Retinoid content, visual responses, and ocular morphology are compromised in the retinas of mice lacking the retinol-binding protein receptor, STRA6. Invest. Ophthalmol. Vis. Sci. 53:3027-3039.
35. Pasutto F, Sticht H, Hammersen G, Gillessen-Kaesbach G, Fitzpatrick DR, Nurnberg G, Brasch F, Schirmer-Zimmermann H, Tolmie JL, Chitayat D, Houge G, Fernandez-Martinez L, Keating S, Mortier G, Hennekam RC, von der Wense A, Slavotinek A, Meinecke P, Bitoun P, Becker C, Nurnberg P, Reis A, Rauch A. 2007. Mutations in STRA6 cause a broad spectrum of malformations including anophthalmia, congenital heart defects, diaphragmatic hernia, alveolar capillary dysplasia, lung hypoplasia, and mental retardation. Am. J. Hum. Genet. 80:550-560.
36. Alapatt P, Guo F, Komanetsky SM, Wang S, Cai J, Sargsyan A, Rodriguez Diaz E, Bacon BT, Aryal P, Graham TE. 2013. Liver retinol transporter and receptor for serum retinol binding protein (RBP4). J. Biol. Chem. 288:1250-1265.
37. Blaner WS. 2007. STRA6, a cell-surface receptor for retinol-binding protein: the plot thickens. Cell Metab. 5:164-166.
38. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. 2005. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436:356-362.
39. Shirakami Y, Lee SA, Clugston RD, Blaner WS. 2012. Hepatic metabolism of retinoids and disease associations. Biochim. Biophys. Acta 1821: 124-136.
40. Kawaguchi R, Zhong M, Kassai M, Ter-Stepanian M, Sun H. 2012. STRA6-catalyzed vitamin A influx, efflux, and exchange. J. Membr. Biol. 245:731-745.
41. Berry DC, Jin H, Majumdar A, Noy N. 2011. Signaling by vitamin A and retinol-binding protein regulates gene expression to inhibit insulin responses. Proc. Natl. Acad. Sci. U. S. A. 108:4340-4345.
42. Berry DC, O'Byrne SM, Vreeland AC, Blaner WS, Noy N. 2012. Cross talk between signaling and vitamin A transport by the retinol-binding protein receptor STRA6. Mol. Cell. Biol. 32:3164-3175.
43. Norseen J, Hosooka T, Hammarstedt A, Yore MM, Kant S, Aryal P, Kiernan UA, Phillips DA, Maruyama H, Kraus BJ, Usheva A, Davis RJ, Smith U, Kahn BB. 2012. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and Toll-like receptor 4-dependent and retinol-independent mechanism. Mol. Cell. Biol. 32:2010-2019.
44. Xia M, Liu Y, Guo H, Wang D, Wang Y, Ling W. 2013. Retinol binding protein 4 stimulates hepatic SREBP-1 and increases lipogenesis through PGC-1beta-dependent pathway. Hepatology 58:564-575.
45. Farjo KM, Farjo RA, Halsey S, Moiseyev G, Ma JX. 2012. Retinolbinding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinolindependent mechanism. Mol. Cell. Biol. 32:5103-5115.
46. Schupp M, Lefterova MI, Janke J, Leitner K, Cristancho AG, Mullican SE, Qatanani M, Szwergold N, Steger DJ, Curtin JC, Kim RJ, Suh M, Albert MR, Engeli S, Gudas LJ, Lazar MA. 2009. Retinol saturase promotes adipogenesis and is downregulated in obesity. Proc. Natl. Acad. Sci. U. S. A. 106:1105-1110.
47. Wilson CG, Schupp M, Burkhardt BR, Wu J, Young RA, Wolf BA. 2010. Liver-specific overexpression of pancreatic-derived factor (PANDER) induces fasting hyperglycemia in mice. Endocrinology 151: 5174-5184.
48. Schupp M, Cristancho AG, Lefterova MI, Hanniman EA, Briggs ER, Steger DJ, Qatanani M, Curtin JC, Schug J, Ochsner SA, McKenna NJ, Lazar MA. 2009. Re-expression of GATA2 cooperates with peroxisome proliferator-activated receptor-{gamma} depletion to revert the adipocyte phenotype. J. Biol. Chem. 284:9458-9464.
49. Kawaguchi R, Sun H. 2010. Techniques to study specific cell-surface receptor-mediated cellular vitamin A uptake. Methods Mol. Biol. 652: 341-361.
50. Bouillet P, Sapin V, Chazaud C, Messaddeq N, Decimo D, Dolle P, Chambon P. 1997. Developmental expression pattern of Stra6, a retinoic acid-responsive gene encoding a new type of membrane protein. Mech. Dev. 63:173-186.
51. Smas CM, Sul HS. 1993. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell 73:725-734.
52. Schulz TJ, Huang TL, Tran TT, Zhang H, Townsend KL, Shadrach JL, Cerletti M, McDougall LE, Giorgadze N, Tchkonia T, Schrier D, Falb D, Kirkland JL, Wagers AJ, Tseng YH. 2011. Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc. Natl. Acad. Sci. U. S. A. 108:143-148.
53. D'Ambrosio DN, Clugston RD, Blaner WS. 2011. Vitamin A metabolism: an update. Nutrients 3:63-103.
54. Green H, Meuth M. 1974. An established pre-adipose cell line and its differentiation in culture. Cell 3:127-133.
55. Teng M, Duong TT, Johnson AT, Klein ES, Wang L, Khalifa B, Chandraratna RA. 1997. Identification of highly potent retinoic acid receptor alpha-selective antagonists. J. Med. Chem. 40:2445-2451.
56. Faraonio R, Galdieri M, Colantuoni V. 1993. Cellular retinoic-acidbinding-protein and retinol-binding-protein mRNA expression in the cells of the rat seminiferous tubules and their regulation by retinoids. Eur. J. Biochem. 211:835-842.
57. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. 270:26746-26749.
58. Kawaguchi R, Yu J, Wiita P, Honda J, Sun H. 2008. An essential ligand-binding domain in the membrane receptor for retinol-binding protein revealed by large-scale mutagenesis and a human polymorphism. J. Biol. Chem. 283:15160-15168.
59. ReznikoffCA, Bertram JS, Brankow DW, Heidelberger C. 1973. Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res. 33:3239-3249.
60. Floyd ZE, Stephens JM. 2003. STAT5A promotes adipogenesis in nonprecursor cells and associates with the glucocorticoid receptor during adipocyte differentiation. Diabetes 52:308-314.
61. Belatik A, Hotchandani S, Bariyanga J, Tajmir-Riahi HA. 2012. Binding sites of retinol and retinoic acid with serum albumins. Eur. J. Med. Chem. 48:114-123.
62. Futterman S, Heller J. 1972. The enhancement of fluorescence and the decreased susceptibility to enzymatic oxidation of retinol complexed with bovine serum albumin, lactoglobulin, and the retinol-binding protein of human plasma. J. Biol. Chem. 247:5168-5172.
63. Friebe D, Neef M, Erbs S, Dittrich K, Kratzsch J, Kovacs P, Bluher M, Kiess W, Korner A. 2011. Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children. Int. J. Pediatr. Obes. 6:e345-e352.
64. Henze A, Frey SK, Raila J, Tepel M, Scholze A, Pfeiffer AF, Weickert MO, Spranger J, Schweigert FJ. 2008. Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels. Diabetes 57:3323-3326.
65. Mody N, Graham TE, Tsuji Y, Yang Q, Kahn BB. 2008. Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. Am. J. Physiol. Endocrinol. Metab. 294:E785-E793.
66. Isken A, Golczak M, Oberhauser V, Hunzelmann S, Driever W, Imanishi Y, Palczewski K, von Lintig J. 2008. RBP4 disrupts vitamin A uptake homeostasis in a STRA6-deficient animal model for Matthew-Wood syndrome. Cell Metab. 7:258-268.
67. Mills JP, Furr HC, Tanumihardjo SA. 2008. Retinol to retinol-binding protein (RBP) is low in obese adults due to elevated apo-RBP. Exp. Biol. Med. 233:1255-1261.
68. Frey SK, Spranger J, Henze A, Pfeiffer AF, Schweigert FJ, Raila J. 2009. Factors that influence retinol-binding protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus. Metabolism 58:1386-1392.
69. Frey SK, Nagl B, Henze A, Raila J, Schlosser B, Berg T, Tepel M, Zidek W, Weickert MO, Pfeiffer AF, Schweigert FJ. 2008. Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver. Lipids Health Dis. 7:29.
70. Tsutsumi C, Okuno M, Tannous L, Piantedosi R, Allan M, Goodman DS, Blaner WS. 1992. Retinoids and retinoid-binding protein expression in rat adipocytes. J. Biol. Chem. 267:1805-1810.
71. Dani C, Smith AG, Dessolin S, Leroy P, Staccini L, Villageois P, Darimont C, Ailhaud G. 1997. Differentiation of embryonic stem cells into adipocytes in vitro. J. Cell Sci. 110(Part 11):1279-1285.
72. Bost F, Caron L, Marchetti I, Dani C, Le Marchand-Brustel Y, Binetruy B. 2002. Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage. Biochem. J. 361:621-627.
73. Monteiro MC, Wdziekonski B, Villageois P, Vernochet C, Iehle C, Billon N, Dani C. 2009. Commitment of mouse embryonic stem cells to the adipocyte lineage requires retinoic acid receptor beta and active GSK3. Stem Cells Dev. 18:457-463.
74. White JA, Beckett-Jones B, Guo YD, Dilworth FJ, Bonasoro J, Jones G, Petkovich M. 1997. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450. J. Biol. Chem. 272:18538-18541.
75. Preitner F, Mody N, Graham TE, Peroni OD, Kahn BB. 2009. Longterm fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosis. Am. J. Physiol. Endocrinol. Metab. 297: E1420-E1429.
76. McIlroy GD, Delibegovic M, Owen C, Stoney PN, Shearer KD, McCaffery PJ, Mody N. 2012. Fenretinide treatment prevents diet-induced obesity in association with major alterations in retinoid homeostatic gene expression in adipose, liver and hypothalamus. Diabetes 62:825-836.
77. Aeberli I, Biebinger R, Lehmann R, L'Allemand D, Spinas GA, Zimmermann MB. 2007. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J. Clin. Endocrinol. Metab. 92:4359-4365.
78. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, Schwartz GJ, Scherer PE. 2007. Obesityassociated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117:2621-2637.
79. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270:12953-12956.